Critical role of Th17 cells in development of autoimmune hemolytic anemia

Experimental Hematology

Volumn 40, Issue 12, 2012, Pages

  Xu, Lin ^a   Zhang, Tenglong ^b   Liu, Zhongmin ^c   Li, Qinchuan ^c   Xu, Zengguang ^c   Ren, Tao ^c  

^a ZUNYI MEDICAL UNIVERSITY   (China)

^b QINGDAO MUNICIPAL HOSPITAL   (China)

^c TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROCYTE ANTIBODY; HEMOGLOBIN; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 17; LACTATE DEHYDROGENASE;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSE; DISEASE ACTIVITY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; IN VIVO STUDY; LYMPHOCYTE FUNCTION; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TH17 CELL;

EID: 84868673026     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2012.08.008     Document Type: Article

References (42)

1. Zeerleder S. Autoimmune haemolytic anaemia-a practical guide to cope with a diagnostic and therapeutic challenge. Neth J Med 2011, 69:177-184.
2. Mqadmi A., Zheng X., Yazdanbakhsh K. CD4+CD25+ regulatory T cells control induction of autoimmune hemolytic anemia. Blood 2005, 105:3746-3748.
3. Baek S.W., Lee M.W., Ryu H.W., et al. Clinical features and outcomes of autoimmune hemolytic anemia: a retrospective analysis of 32 cases. Korean J Hematol 2011, 46:111-117.
4. Klein N.P., Ray P., Carpenter D., et al. Rates of autoimmune diseases in Kaiser Permanente for use in vaccine adverse event safety studies. Vaccine 2010, 28:1062-1068.
5. Eaton W.W., Rose N.R., Kalaydjian A., Pedersen M.G., Mortensen P.B. Epidemiology of autoimmune diseases in Denmark. J Autoimmun 2007, 29:1-9.
6. Pruss A., Salama A., Ahrens N., et al. Immune hemolysis-serological and clinical aspects. Clin Exp Med 2003, 3:55-64.
7. Hoyer K.K., Kuswanto W.F., Gallo E., Abbas A.K. Distinct roles of helper T-cell subsets in a systemic autoimmune disease. Blood 2009, 113:389-395.
8. Ahmad E., Elgohary T., Ibrahim H. Naturally occurring regulatory T cells and interleukins 10 and 12 in the pathogenesis of idiopathic warm autoimmune hemolytic anemia. J Invest Allergol Clin Immunol 2011, 21:297-304.
9. Michel M. Classification and therapeutic approaches in autoimmune hemolytic anemia: an update. Expert Rev Hematol 2011, 4:607-618.
10. Roncarolo M.G., Battaglia M. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat Rev Immunol 2007, 7:585-598.
11. Hoyer K.K., Wolslegel K., Dooms H., Abbas A.K. Targeting T cell-specific costimulators and growth factors in a model of autoimmune hemolytic anemia. J Immunol 2007, 179:2844-2850.
12. Hall A.M., Vickers M.A., Barker R.N., Erwig L.P. Helper T cells point the way to specific immunotherapy for autoimmune disease. Cardiovasc Hematol Disord Drug Targets 2009, 9:159-166.
13. Steinman L. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 2007, 13:139-145.
14. Henriques A., Inês L., Couto M., et al. Frequency and functional activity of Th17, Tc17 and other T-cell subsets in systemic lupus erythematosus. Cell Immunol 2010, 264:97-103.
15. Feinen B., Jerse A.E., Gaffen S.L., Russell M.W. Critical role of Th17 responses in a murine model of Neisseria gonorrhoeae genital infection. Mucosal Immunol 2010, 3:312-321.
16. Wan Q., Kozhaya L., ElHed A., et al. Cytokine signals through PI-3 kinase pathway modulate Th17 cytokine production by CCR6+ human memory T cells. J Exp Med 2011, 208:1875-1887.
17. Brand S. Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease. Gut 2009, 58:1152-1167.
18. Shen H., Goodall J.C., Hill Gaston J.S. Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum 2009, 60:1647-1656.
19. Waite J.C., Skokos D. Th17 response and inflammatory autoimmune diseases. Int J Inflamm 2012, 2012:819467.
20. Mitsdoerffer M., Lee Y., Jäger A., et al. Proinflammatory T helper type 17 cells are effective B-cell helpers. Proc Natl Acad Sci U S A 2010, 107:14292-14297.
21. Shah K., Lee W.W., Lee S.H., et al. Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus. Arthritis Res Ther 2010, 12:R53.
22. Playfair J.H., Marshall-Clarke S. Induction of red cell autoantibodies in normal mice. Nat New Biol 1973, 243:213-214.
23. Lee N.J., Rigby R.J., Gill H., et al. Multiple loci are linked with anti-red blood cell antibody production in NZB mice-comparison with other phenotypes implies complex modes of action. Clin Exp Immunol 2004, 13:39-46.
24. Yazdanbakhsh K., Kang S., Tamasauskas D., Sung D., Scaradavou A. Complement receptor 1 inhibitors for prevention of immune-mediated red cell destruction: potential use in transfusion therapy. Blood 2003, 101:5046-5052.
25. Streeck H., Cohen K.W., Jolin J.S., et al. Rapid ex vivo isolation and long-term culture of human Th17 cells. J Immunol Methods 2008, 333:115-125.
26. Bending D., De la Peña H., Veldhoen M., et al. Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J Clin Invest 2009, 19:565-572.
27. Pelletier M., Maggi L., Micheletti A., et al. Evidence for a cross-talk between human neutrophils and Th17 cells. Blood 2010, 115:335-343.
28. Bending D., Newland S., Krejcí A., Phillips J.M., Bray S., Cooke A. Epigenetic changes at Il12rb2 and Tbx21 in relation to plasticity behavior of Th17 cells. J Immunol 2011, 86:3373-3382.
29. Schmitz J., Owyang A., Oldham E., et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005, 23:479-490.
30. Chung D.R., Kasper D.L., Panzo R.J., et al. CD4+ T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism. J Immunol 2003, 170:1958-1963.
31. Yang L., Anderson D.E., Baecher-Allan C., et al. IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature 2008, 454:350-352.
32. Volpe E., Servant N., Zollinger R., et al. A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses. Nat Immunol 2008, 9:650-657.
33. Manel N., Unutmaz D., Littman D.R. The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat Immunol 2008, 9:641-649.
34. Wilson N.J., Boniface K., Chan J.R., et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 2007, 8:950-957.
35. van Beelen A.J., Zelinkova Z., Taanman-Kueter E.W., et al. Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity 2007, 27:660-669.
36. Acosta-Rodriguez E.V., Napolitani G., Lanzavecchia A., Sallusto F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 2007, 8:942-949.
37. Korn T., Bettelli E., Oukka M., Kuchroo V.K. IL-17 and Th17 cells. Annu Rev Immunol 2009, 27:485-517.
38. Garrett-Sinha L.A., John S., Gaffen S.L. IL-17 and the Th17 lineage in systemic lupus erythematosus. Curr Opin Rheumatol 2008, 20:519-525.
39. He H.S., Xie Y.H. Change and significance of Th17 cells and its secretive IL-17 in patients with autoimmune hemolytic anemia. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2011, 27:662-663.
40. Barcellini W., Zaja F., Zaninoni A., et al. Low dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biological studies. Blood 2012, 119(16):3691-3697.
41. Hall A.M., Zamzami O.M., Whibley N., et al. Production of the effector cytokine interleukin-17, rather than IFN-γ, is more strongly associated with autoimmune hemolytic anemia. Haematologica 2012 Mar 14, [Epub ahead of print].
42. Nakae S., Komiyama Y., Nambu A., et al. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 2002, 17:375-387.